Gottlieb A, Zhao Y, Odom DM, Tran MH, Strober B. Secukinumab's time to psoriasis response on patient-reported psoriasis symptoms (ERASURE Study). Poster presented at the 15th Annual Las Vegas Dermatology Seminar; October 30, 2014. Las Vegas, NV.
Gottlieb A, Zhao Y, Odom DM, Tran MH, Strober B. Secukinumab's time to psoriasis response on patient-reported symptoms (ERASURE Study). Poster presented at the 33rd Anniversary Fall Clinical Dermatology Conference; October 16, 2014. Las Vegas, NV.
Matharu M, Pascual J, Nilsson Remahl I, Odom D, Gutierrez L, Andrews E, Largent J, Johannes C. EHMTI-0192. Onabotulinumtoxina prophylaxis in chronic migraine utilization and patient characteristics: observational study in the European Union. Poster presented at the 4th European Headache and Migraine Trust International Congress 2014; September 2014. Copenhagen, Denmark. [abstract] J. Headache Pain. 2014 Sep 18; 15(Suppl 1):G24. doi: 10.1186/1129-2377-15-S1-G24
Odom DM, Chirila C, Sherrill EH, Wang J, Sherif BN. Practical issues when conducting network meta-analyses with a limited number of studies. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 3, 2014.
Odom DM, Mladsi DM, Saag KG, Sherif BN, Miles L, Ronquest N, Wang J. Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews. Clin Ther. 2014 Jun;36(6):906-17. doi: 10.1016/j.clinthera.2014.04.012.
Gottlieb AB, Zhao Y, Odom DM, Tran MH, Strober B. Secukinumab's time to psoriasis response on patient-reported psoriasis symptoms (ERASURE study). Poster presented at the Society of Dermatology Physicians Assistants Annual Summer Dermatology Conference; May 29, 2014. Indianapolis, IN. Previously presented at the 72nd Annual Meeting of the American Academy of Dermatology.